AstraZeneca | AZN - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

AstraZeneca

AstraZeneca reported $8.83B in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Alcon AG ALC:SW USD 1.31B 136M
Almirall SA ALM:SM EUR 335.97M 9.51M
Amgen AMGN:US USD 4.42B 669M
Artemis Alpha ATS:LN GBP -16320000 10.05M
AstraZeneca AZN:LN USD 8.83B 130M
Bayer BAYN:GR EUR 8.66B 1.42B
Biogen BIIB:US USD 1.8B 172.9M
Bristol-Myers Squibb BMY:US USD 8.77B 114M
Eli Lilly LLY:US USD 5.33B 420.4M
Fresenius FRE:GR EUR 2.51B 273M
Fresenius Medical Care FME:GR EUR 1.15B 198.52M
Galapagos GLPG:NA EUR 183.6M 75.24M
Gilead Sciences GILD:US USD 4.95B 1.04B
GlaxoSmithKline GSK:LN GBP 5.05B 151M
Hikma Pharmaceutical HIK:LN USD 642M 19M
Lonza Group LONN:SW CHF 1.24B 46M
Merck & Co MRK:US USD 11.14B 1.15B
Novartis NOVN:VX USD 9.38B 215M
Orion ORNBV:FH EUR 156.1M 900K
Pfizer PFE:US USD 13.26B 1.21B
Philips PHIA:NA EUR 1.76B 465M
Recordati REC:IM EUR 387.71M 55.88M
Regeneron Pharmaceuticals REGN:US USD 2.7B 169.2M
Roche Holding ROG:VX 22.04B 696M
UCB UCB:BB 1.76B 317M